Stock TERN TERNS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Terns Pharmaceuticals, Inc.

Equities

TERN

US8808811074

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
6 USD +2.39% Intraday chart for Terns Pharmaceuticals, Inc. +1.69% -7.55%
May. 13 Terns Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 08 Terns Pharmaceuticals, Inc. Announces Executive Changes CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
TERNS PHARMACEUTICALS TO PARTICIPATE IN UBS OBESITY THERAPEUTICS DAY
AQ
Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day
GL
Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates
GL
Terns Pharmaceuticals : Corporate Presentation May 2024
PU
Terns Pharmaceuticals Announces Leadership Changes
GL
Terns Pharmaceuticals Announces Leadership Changes
AQ
Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024
GL
TERNS PHARMACEUTICALS REPORTS INDUCEMENT GRANT TO NEW EMPLOYEE UNDER NASDAQ LISTING RULE 5635(4)
AQ
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
GL
Terns Pharmaceuticals : Corporate Presentation April 2024
PU
Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation
GL
Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
GL
Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
AQ
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
GL
Thinking about buying stock in Marathon Digital, Assertio, Ocean Biomedical, Terns Pharmaceuticals, or NextCure?
PR
Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia
GL
TERNS PHARMACEUTICALS REPORTS INDUCEMENT GRANT TO NEW EMPLOYEE UNDER NASDAQ LISTING RULE 5635(4)
AQ
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
GL
Terns Pharmaceuticals : Corporate Presentation March 2024
PU
Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TERN Stock
  4. News Terns Pharmaceuticals, Inc.
  5. Press Releases